← Open Payments lookup

MARKITTA BROWN: Open Payments

NPI 1992157002 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$550 in 31 payments from 12 companies in 2025. Trend: 2023 $533 · 2024 $704 · 2025 $550

Food & beverage: $550
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.5$88
Teva Pharmaceuticals USA, Inc.4$77
Vanda Pharmaceuticals Inc.4$75
Indivior Inc.4$73
E.R. Squibb & Sons, L.L.C.3$44
ABBVIE INC.3$44
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$37
Lundbeck LLC2$34
Janssen Pharmaceuticals, Inc1$25
Braeburn Inc.1$22

Products named: REXULTI, SUBLOCADE, AUSTEDO XR, COBENFY, VRAYLAR, HETLIOZ, FANAPT, CAPLYTA.

Industry payments across KY — which companies pay providers there.